Nobuhiro Hattori

Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib

Haruki Uojima, Makoto Chuma, Yoshiaki Tanaka et al. · Liver Cancer · 2019 · 90 citations · Full text

Medicine, Oncology, Pharmacology +17

L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis

Hiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya et al. · Clinical Gastroenterology and Hepatology · 2014 · 76 citations

Medicine, Pharmacology, Pharmacotherapy +6

<i>Wisteria floribunda</i> agglutinin positive human Mac‐2‐binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients

Nobuharu Tamaki, Masayuki Kurosaki, Atsushi Kuno et al. · Hepatology Research · 2015 · 63 citations

Medicine, Oncology, Pathology +17

Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma

Makoto Chuma, Haruki Uojima, Kazushi Numata et al. · Cancers · 2020 · 54 citations · Full text

Medicine, Oncology, Pharmacology +16

&lt;p&gt;Safety and Efficacy of Lenvatinib Treatment in Child–Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis&lt;/p&gt;

Katsuaki Ogushi, Makoto Chuma, Haruki Uojima et al. · Clinical and Experimental Gastroenterology · 2020 · 54 citations · Full text

Medicine, Oncology, Pharmacology +16